Medicare Enrolled
Dr. Peter Serpico, D.O.
Pulmonary Disease · Yardley, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Serpico from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Serpico?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Serpico
Dr. Peter Serpico is a pulmonary disease specialist in Yardley, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Serpico performed 2,598 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Serpico received a total of $11,460 from 41 pharmaceutical and/or device companies across 590 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Serpico is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 6% volume in PA
$11,460 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,598
Medicare services
Top 6% in PA for pulmonary disease
Not available
Unique patients (not deduplicated)
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,008 | $97 | $224 |
| Health risk assessment administration and interpretation This procedure involves administering a health risk assessment to a patient and interpreting the results. |
243 | $2 | $10 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
237 | $21 | $130 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
227 | $43 | $160 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
217 | $47 | $160 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
194 | $65 | $157 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
158 | $117 | $344 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
106 | $25 | $105 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
84 | $108 | $297 |
| Lung cancer screening counseling visit A visit to discuss the need for lung cancer screening using a low-dose CT scan. This service is used to determine eligibility and facilitate shared decision making. |
82 | $29 | $119 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
16 | $70 | $148 |
| Overnight continuous oxygen level test This test measures oxygen levels in the blood continuously overnight using a device attached to the ear or finger. |
14 | $20 | $118 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
12 | $15 | $40 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$11,460
Total received (2018-2024)
Avg $1,637/year across 7 years
Top 17% in PA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
590
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,133
2023
$2,365
2022
$1,406
2021
$765
2020
$1,582
2019
$2,144
2018
$1,064
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$769
HARMONY BIOSCIENCES LLC
$207
GENZYME CORPORATION
$156
Regeneron Healthcare Solutions, Inc.
$138
Electromed, Inc.
$115
JAZZ PHARMACEUTICALS INC.
$110
Amgen Inc.
$91
Axsome Therapeutics, Inc.
$88
Boehringer Ingelheim Pharmaceuticals, Inc.
$78
Inspire Medical Systems, Inc.
$46
Vifor Pharma, Inc.
$46
Takeda Pharmaceuticals U.S.A., Inc.
$45
Avadel CNS Pharmaceuticals, LLC
$44
Genentech USA, Inc.
$40
Philips North America LLC
$29
Mallinckrodt Hospital Products Inc.
$29
Baxter Healthcare
$25
Novartis Pharmaceuticals Corporation
$21
Insmed, Inc.
$21
Mylan Specialty L.P.
$20
United Therapeutics Corporation
$13
Top 3 companies account for 53.1% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,961
GlaxoSmithKline, LLC.
$2,372
Boehringer Ingelheim Pharmaceuticals, Inc.
$707
Genentech USA, Inc.
$576
GENZYME CORPORATION
$450
Mylan Specialty L.P.
$449
Regeneron Healthcare Solutions, Inc.
$412
Novartis Pharmaceuticals Corporation
$405
Actelion Pharmaceuticals US, Inc.
$355
Insmed, Inc.
$334
Philips Electronics North America Corporation
$248
JAZZ PHARMACEUTICALS INC.
$244
HARMONY BIOSCIENCES LLC
$207
Axsome Therapeutics, Inc.
$186
Sunovion Pharmaceuticals Inc.
$179
Amgen Inc.
$174
Takeda Pharmaceuticals U.S.A., Inc.
$165
Harmony Biosciences LLC
$159
Electromed, Inc.
$147
Resmed Corp
$83
Jazz Pharmaceuticals Inc.
$78
Avadel CNS Pharmaceuticals, LLC
$68
Inspire Medical Systems, Inc.
$46
Vifor Pharma, Inc.
$46
Circassia Pharmaceuticals Inc
$42
Inogen, Inc.
$34
Merck Sharp & Dohme LLC
$33
Pulmonx Corporation
$30
Philips North America LLC
$29
Mallinckrodt Hospital Products Inc.
$29
ANI Pharmaceuticals, Inc.
$26
Teva Pharmaceuticals USA, Inc.
$26
Baxter Healthcare
$25
Merck Sharp & Dohme Corporation
$23
Mallinckrodt LLC
$20
Janssen Pharmaceuticals, Inc
$19
kaleo, Inc.
$17
Shire North American Group Inc
$17
ADVANCED RESPIRATORY, INC
$13
United Therapeutics Corporation
$13
Eisai Inc.
$13
Top 3 companies account for 52.7% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIR 11 · AIRSENSE · AIRSUPRA · ANORO · ANORO ELLIPTA · ARALAST · AREXVY · ASMANEX · AUVI-Q · AirDuo Digihaler · Arikayce · Astral · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CHARTIS CATHETER · CINQAIR · DUPIXENT · Dayvigo · FASENRA · GLASSIA · Hillrom - Life 2000 Ventilation System · IMFINZI · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · LONHALA MAGNAIR · LUMRYZ · NIOX VERO · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · PURIFIED CORTROPHIN GEL · Perforomist · S&RC Und · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · Trilogy 100 · UPTRAVI · Utibron · WAKIX · Wakix · Wellcentive Undiv · XARELTO · XOLAIR · XYREM · XYWAV · Xolair · YUPELRI · Yupelri · ZEPHYR DELIVERY CATHETER · Zemaira · inCourage
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
149
County median income
$111,951
Nearest hospital to ZIP centroid (approximate)
ST MARY MEDICAL CENTER
4.4 mi
4.4 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Serpico is a clinical cardiology specialist, with above-average Medicare volume (top 6% in PA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Serpico experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Serpico performed 1,008 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Serpico receive payments from pharmaceutical companies?
Yes. Dr. Serpico received a total of $11,460 from 41 companies across 590 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Serpico's costs compare to other pulmonary diseases in Yardley?
Dr. Serpico's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Serpico) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Yardley
Browse pulmonary diseases in Yardley ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in PA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in PA
Which PA pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology